You are viewing an inactive listing

This listing is not currently available. You can either be notified when it becomes available or browse nearby active listings below.

Click here to view additional nearby listings or search by keyword.

Rochester, Minnesota 55905

  • Breast Cancer


The purpose of this research is to evaluate whether repeating a screening Molecular Breast Imaging (MBI) study two years after an initial screening MBI study further improves breast cancer detection in women with dense breast tissue.


Inclusion Criteria: - Past prior screening mammogram within the previous 11-24 months interpreted as heterogeneously dense or extremely dense and negative or benign [Breast Imaging Reporting and Data System (BI-RADS) Category 1 or 2] Exclusion Criteria: Subjects will be excluded if they: - Are unable to understand and sign the consent form - Are pregnant or lactating - Are physically unable to sit upright and still for 40 minutes - Have self-reported signs or symptoms that may suggest breast cancer (palpable mass, bloody nipple discharge, axillary mass, etc.) - Have had needle biopsy within 3 months, or breast surgery or radiation within 1 year prior to the study - Are currently receiving chemotherapy or tamoxifen, raloxifene, or an aromatase inhibitor for adjuvant therapy or chemoprevention - Have undergone bilateral mastectomy - Have had a prior MBI within 20 months of scheduled study MBI.



Primary Contact:

Principal Investigator
Deborah Rhodes, MD
Mayo Clinic

Backup Contact:


Location Contact:

Rochester, Minnesota 55905
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: June 12, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.